Influenza A - Human influenza
This assay is only available as part of a panel and cannot be ordered individually.
Human Influenza A viruses are medically important pathogens that cause significant morbidity and mortality throughout the world. The emergence of the 2009 H1N1 influenza A virus has led to increased vigilance in monitoring these infections. Availability of several antiviral drugs coupled with differing resistance patterns between subtypes has led to a need for diagnostic testing that is able to rapidly and accurately subtype influenza A specimens. Utilizing molecular testing for subtyping enables the clinician to choose appropriate antiviral drug therapy as well as assisting in epidemiological tracking of influenza outbreaks.
Specimens are approved for testing in New York only when indicated in the Specimen Information field above. The CPT codes provided are based on Viracor Eurofins' interpretation of the American Medical Association's Current Procedural Terminology (CPT) codes and are provided for informational purposes only. CPT coding is the sole responsibility of the billing party. Questions regarding coding should be addressed to your local Medicare carrier. Viracor Eurofins assumes no responsibility for billing errors due to reliance on the CPT codes illustrated in this material.